From: DNA Polymerases as targets for gene therapy of hepatocellular carcinoma
S-Phase fraction
P-value
Blank control
Ad/AFP
Ad/AFP-amiR-AFP-Casp
HepG2
37.25%
42.00%
23.14%
<0.01
Hep3B
38.51%
36.55%
45.19%
>0.05
HL7702
23.40%
27.21%
25.69%